Skip to main content
SpringerLink
Log in

Thrombozytenaggregationshemmer zur Prävention der Präeklampsie

Metaanalyse individueller Patientendaten

Thrombocyte aggregation inhibitors for the prevention of pre-eclampsia

Meta-analysis of individual patient data

  • Für Sie gelesen
  • Published:
Der Gynäkologe Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Bodnar LM, Ness RB, Harger GF, Roberts JM (2005) Inflammation and triglycerides partially mediate the effect of prepregnancy body mass index on the risk of preeclampsia. Am J Epidemiol 162: 1198–1206

    Article  PubMed  Google Scholar 

  2. Bodnar LM, Catov JM, Klebanoff MA et al. (2007) Prepragnancy body mass index and the occurrence of severe hypertensive disorders of pregnancy. Epidemology 18: 234–239

    Article  Google Scholar 

  3. Bussolino F, Benedetto C, Massobrio M, Camussi G (1995) Maternal vascular prostacyclin activity in pre-eclampsia. Thromb Haemost 74: 1059–1063

    Google Scholar 

  4. CLASP (Collaborative Low-dose Aspirin Study in Pregnancy) (1994) A randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. Lancet 343: 619–629

    Article  Google Scholar 

  5. Coomarasamy A, Papaioannou S, Gee H, Khan KS (2001) Aspirin for the prevention of preeclampsia in women with abnormal uterine artery Doppler: a meta-analysis. Obstet Gynecol 98: 861–866

    Article  PubMed  CAS  Google Scholar 

  6. Critchley H, MacLean A, Poston L, Walker J (eds) (2003) Pre-eclampsia, 1st edn. RCOG, London

  7. Duley L, Henderson-Smart DJ, Knight M, King J (2003) Antiplatelet agnets for preventing pre-eclampsia and its complications. Cochrane Database Syst Rev 1: CD004659

    Google Scholar 

  8. Ebrasy A, Ibrahim M, Marzook A, Yousef D (2005) Usefulness of aspirin therapy in high-risk pregnant women with abnormal uterine artery doppler ultrasound at 14–16 weeks pregnancy: randomized controlled clinical trial. Croat Med J 46: 826–831

    Google Scholar 

  9. Nørgård B, Puhó E, Czeizel AE et al. (2005) Aspirin use during early pregnancy and the risk of congenital abnormalities: a population-based case-control study. Am J Obstet Gynecol 192: 922–923

    Article  PubMed  CAS  Google Scholar 

  10. Redman CW, Sargent IL (1978) Latest advances in understanding pre-eclampsia. BMJ 1: 467–469

    Article  PubMed  CAS  Google Scholar 

  11. Ruano R, Fontes RS, Zugaib M (2005) Prevention of preeclampsia with low-dose-aspirin. A systematic review and meta-analysis of the main randomized controlled trials. Clinics 60: 407–414

    Article  PubMed  Google Scholar 

Download references

Interessenkonflikt

Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.

Author information

Authors and Affiliations

  1. Frauenklinik, Krankenhaus der Augustinerinnen, Jakobstraße 27-31, 50678, Köln, Deutschland

    J. Bauer &  J. Schmolling

Authors
  1. J. Bauer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. Schmolling
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to J. Schmolling.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bauer, J., Schmolling, J. Thrombozytenaggregationshemmer zur Prävention der Präeklampsie. Gynäkologe 40, 908–910 (2007). https://doi.org/10.1007/s00129-007-2065-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00129-007-2065-9

Search

Navigation